Literature DB >> 7789638

Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486.

M Kusunoki1, G J Cooney, T Hara, L H Storlien.   

Abstract

Fat feeding produces whole-body insulin resistance and decreased glucose uptake in muscle tissue of rats. To examine the effect of glucocorticoid blockade on the insulin resistance caused by high-fat feeding, four groups of rats were fed diets high in starch (70% of calories) or fat (59% of calories) for 4 weeks with or without the antiglucocorticoid RU486 (69.8 mumol.kg-1.day-1) in the food. Whole-body insulin action was assessed by the euglycemic clamp technique at an upper physiological insulin level with bolus 2-[3H]deoxyglucose to determine individual tissue insulin-stimulated glucose uptake. Whole-body glucose utilization (clamp glucose infusion rate [GIR]) was decreased by high-fat feeding (GIR 68.3 +/- 12.2 vs. 182.6 +/- 12.8 mumol.kg-1.min-1 for the starch-fed group; P < 0.001). Addition of RU486 to the diet significantly improved (GIR 133.9 +/- 12.8 mumol.kg-1.min-1; P < 0.01), but did not fully reverse, the insulin resistance caused by fat feeding. RU486 was without effect in the starch-fed rats. In skeletal muscles, RU486 ameliorated 62 and 68% of the insulin resistance produced by fat feeding in red quadriceps and extensor digitorum longus hindlimb muscles, respectively, but had no effect in heart or white adipose tissue. These results suggest that glucocorticoids play, in a tissue-specific manner, a role in the maintenance and/or production of insulin resistance produced by high-fat feeding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789638     DOI: 10.2337/diab.44.6.718

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance.

Authors:  Roland Stocker; David E James; Daniel J Fazakerley; Rima Chaudhuri; Pengyi Yang; Ghassan J Maghzal; Kristen C Thomas; James R Krycer; Sean J Humphrey; Benjamin L Parker; Kelsey H Fisher-Wellman; Christopher C Meoli; Nolan J Hoffman; Ciana Diskin; James G Burchfield; Mark J Cowley; Warren Kaplan; Zora Modrusan; Ganesh Kolumam; Jean Yh Yang; Daniel L Chen; Dorit Samocha-Bonet; Jerry R Greenfield; Kyle L Hoehn
Journal:  Elife       Date:  2018-02-06       Impact factor: 8.140

2.  FOXO1 involvement in insulin resistance-related pro-inflammatory cytokine production in hepatocytes.

Authors:  Hongming Miao; Yang Zhang; Zhongyan Lu; Qin Liu; Lixia Gan
Journal:  Inflamm Res       Date:  2012-01-06       Impact factor: 4.575

3.  Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.

Authors:  J Ruzzin; A S Wagman; J Jensen
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

4.  Serum amyloid A attenuates cellular insulin sensitivity by increasing JNK activity in 3T3-L1 adipocytes.

Authors:  X Y Ye; Y M Xue; J P Sha; C Z Li; Z J Zhen
Journal:  J Endocrinol Invest       Date:  2009-03-26       Impact factor: 4.256

5.  Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.

Authors:  Sriram Gubbi; Ranganath Muniyappa; Susmeeta T Sharma; Shivraj Grewal; Raven McGlotten; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

6.  Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription.

Authors:  Peng Ma; Yao Zhang; Qiying Liang; Youjie Yin; Saifei Wang; Ruolei Han; Chunyu Huo; Hansong Deng
Journal:  iScience       Date:  2021-05-12

7.  Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis.

Authors:  Sona Kang; Linus T Tsai; Yiming Zhou; Adam Evertts; Su Xu; Michael J Griffin; Robbyn Issner; Holly J Whitton; Benjamin A Garcia; Charles B Epstein; Tarjei S Mikkelsen; Evan D Rosen
Journal:  Nat Cell Biol       Date:  2014-12-15       Impact factor: 28.824

8.  Fat feeding potentiates the diabetogenic effect of dexamethasone in Wistar rats.

Authors:  Shanmugam Sivabalan; Shanmugam Renuka; Venugopal P Menon
Journal:  Int Arch Med       Date:  2008-05-23

9.  Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity.

Authors:  Takeshi Hashimoto; Junsuke Igarashi; Arif U Hasan; Koji Ohmori; Masakazu Kohno; Yukiko Nagai; Tetsuo Yamashita; Hiroaki Kosaka
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

10.  Mitigation of metabolic dyshomeostasis by glucocorticoid-receptor antagonism: Insights from animal and human studies.

Authors:  Aishwariya Madhavan; Kusuma Murali; Vaishnavi Raghavendra; Apurva Kumar Ramesh Joshi
Journal:  EXCLI J       Date:  2020-09-09       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.